Dr. Robert Gray, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-677-5799 |
Benjamin Randal Meis, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-730-4633 |
Adnan Mehboob, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-730-4633 |
Percival Carlos Hargrove, PA Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-677-2668 |
Dr. Matthew John Cazan Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-677-2549 |
News Archive
Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.
Khanh Do, PhD, a postdoctoral fellow at LSU Health New Orleans Neuroscience Center of Excellence, is a member of the first group chosen by the National Institutes of Health (NIH) as NIH Outstanding Scholars in Neuroscience.
The Spanish Bioindustry Association (ASEBIO), in collaboration with the Navarre Society of Development (SODENA), and the government of Navarre, will host BioSpain 2010 the biennial international gathering of experts in the biotechnology sector, in Pamplona from September 29th to October 1st. BioSpain 2010 is honoured to welcome three lecturers of international prestige: Mr. Carlos Cordon-Cardo, Vice-Chair of Pathology & Professor, Columbia University; Mr. Larry Fritz, President & CEO, Covella Pharmaceuticals Inc. and Life Science Venture Partner, Westfield Capital Management Company LP; and Mr. Conny Bogentoft, CEO Karolinska Development AB.
Sanofi-aventis announced today that Health Canada has granted market authorization for Jevtana injection in combination with prednisone for the treatment of patients with metastatic castration resistant prostate cancer, previously treated with a docetaxel-containing treatment regimen.
› Verified 4 days ago